Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2025 07:00 ET | Source: Augustine Therapeutics

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing...
January 27, 2025 08:20 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Announces 2025 MDA National Ambassador Lily Sander

New York, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) has selected Lily Sander from Charlotte, North Carolina, as its 2025 MDA National Ambassador. Sander joins MDA...
June 18, 2024 07:00 ET | Source: NMD Pharma

NMD Pharma Receives IND Clearance from the FDA to initiate a Phase 2 Clinical Trial of NMD670 in Charcot-Marie-Tooth disease in the US

NMD Pharma Receives IND Clearance from the FDA to initiate a Phase 2 Clinical Trial of NMD670 in Charcot-Marie-Tooth disease in the US Aarhus, Denmark, 18 June 2024 – NMD Pharma A/S, a clinical-stage...
June 18, 2024 01:00 ET | Source: NMD Pharma

NMD Pharma Receives IND Clearance from the FDA to initiate a Phase 2 Clinical Trial of NMD670 in Charcot-Marie-Tooth disease in the US

NMD Pharma Receives IND Clearance from the FDA to initiate a Phase 2 Clinical Trial of NMD670 in Charcot-Marie-Tooth disease in the US Aarhus, Denmark, 18 June 2024 – NMD Pharma A/S, a clinical-stage...
September 18, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - Pharnext, MedDay, HELIXMITH, ENCell, InFlectis, Addex, Augustine, DTx Pharma

New York, USA, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - Pharnext, MedDay, HELIXMITH,...
May 16, 2022 02:30 ET | Source: Pharnext

De nouvelles données de l’essai en ouvert PLEO-CMT-FU montrent un bénéfice durable de PXT3003 chez les patients atteints de la maladie de Charcot-Marie-Tooth de type 1A après une durée totale de cinq ans d’essai clinique

De nouvelles données de l’essai en ouvert PLEO-CMT-FU montrent un bénéfice durable de PXT3003 chez les patients atteints de la maladie de Charcot-Marie-Tooth de type 1A après une durée totale de cinq...
October 20, 2021 09:00 ET | Source: CMI

Charcot-Marie-Tooth Disease Market to Surpass US$ 3,459.1 Million by 2028, Says Coherent Market Insights (CMI)

SEATTLE, Oct. 20, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global charcot-marie-tooth disease market is estimated to be valued at US$ 793.9 Million in 2021 and is expected...
July 08, 2021 07:00 ET | Source: NMD Pharma

NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease

PRESS RELEASE NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease The international observational study will be conducted in collaboration with Aarhus University and...
July 08, 2021 02:00 ET | Source: NMD Pharma

NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease

PRESS RELEASE NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease The international observational study will be conducted in collaboration with Aarhus University and...